Recursion (NASDAQ: RXRX) Expands Strategic Partnership With BAYER On Fibrotic Diseases

Max - 0

Dare Bioscience Inc. (NASDAQ: DARE) Announces XACIATO Approval By The FDA...

Max - 0

Arbutus Biopharma Corporation (NASDAQ: ABUS) Announces Interim Phase 1a/1b Clinical Study...

Max - 0

Progenity Inc. (NASDAQ: PROG) Receives Single-Molecule Detection Platform Patent From USPTO

Max - 0

Adcet Bio Inc. (NASDAQ: ACET) Release Preliminary Results From The Phase...

Max - 0

Seelos Therapeutics Inc. (NASDAQ: SEEL) Receive Japanese Patent for SLS-007 and...

Max - 0

Citius Pharmaceuticals Inc. (NASDAQ: CTXR) Completes Patients Recruitment In Phase 3...

Max - 0

Outlook Therapeutics Inc. (NASDAQ: OTLK) Presents NORSE II ONS-5010 Study Data...

Max - 0

Intellia Therapeutics Inc. (NASDAQ: NTLA) Receives MHRA Approval To Amend Phase...

Max - 0

Nabriva Therapeutics plc (NASDAQ: NBRV) Receives marketing Approval for IV and...

Max - 0
1...909192...248Page 91 of 248